Document is current
Any future updates will be listed below
-
Authors
Kim, Seongyeong
Shin, Dongjin
Min, Ahrum
Kim, Minjung
Na, Deukchae
Lee, Han-Byeol
Ryu, Han Suk
Yang, Yaewon
Woo, Go-Un
Lee, Kyung-Hun
Lee, Dae-Won
Kim, Tae-Yong
Lee, Charles
Im, Seock-Ah https://orcid.org/0000-0002-5396-6533
Kim, Jong-Il
-
Funding
Funding for this research was provided by:
Korea Health Industry Development Institute (800-20200226)
National Research Foundation of Korea (0411-20200059)
Seoul National University Hospital (04-2016-0630)
- License Information
-
More Information
Article History
Received: 4 May 2020
Accepted: 5 November 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: As described in the methods, the human material that was used in this study was approved by the Institutional Review Board of Seoul National University Hospital (SNUH) (IRB No: 1402–054-555). The use of biopsy material was approved by the donors (written consent). The xenograft experiment was performed after approval from the Institutional Animal Care and Use Committee of Seoul National University.
: All authors approved the final version of this manuscript.
: Seock-Ah Im is a recipient of research funds from AstraZeneca Inc., Roche, and Pfizer and has consultant and advisory roles for Amen, AstraZeneca, Eisai, Hanmi Corp., Lilly, Novartis, Pfizer, and Roche. Charles Lee is an employee of the Jackson Laboratory. All other authors declare that they have no competing interests.
